In focus · trending topic

Biotechnology

2093 stories · following the connections

Axsome Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018

By Nasdaq OMXMay 1, 2018, 11:01 AM UTC

BioCryst Receives European Medicines Agency Approval for ALPIVAB™ for the Treatment of Influenza

By Nasdaq OMXMay 1, 2018, 10:00 AM UTC

MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call

By Nasdaq OMXApr 30, 2018, 10:30 PM UTC

Arbutus Announces Conference Call to Provide a Corporate Update and First Quarter 2018 Financial Results

By Nasdaq OMXApr 30, 2018, 1:00 PM UTC

NewLink Genetics to Participate in Upcoming Investor Conferences

By Nasdaq OMXApr 30, 2018, 1:00 PM UTC

Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018

By Nasdaq OMXApr 30, 2018, 12:31 PM UTC

Capricor Announces Initiation of HOPE-2 Clinical Trial of CAP-1002 for Duchenne Muscular Dystrophy

By Nasdaq OMXApr 30, 2018, 11:01 AM UTC

ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB

By Nasdaq OMXApr 30, 2018, 11:00 AM UTC